After a Year of Building a Strong Foundation, Barrick Looks to the Next Phase of Value Creation

NEXT STORY
Biocartis Announces Co-Commercialization of the SeptiCyte® RAPID Test on Idylla™ (CE-IVD) and Provides Update on COVID-19 Impact
PREV STORY
Gentherm Provides Update Related to COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights

-- Patient enrollment in Phase III ADVOCATE trial of avacopan in the treatment of ...

author_avatar
NASDAQ Market News

Novartis presents new data demonstrating long-term efficacy, safety and tolerability of Aimovig® (erenumab) in patients with chronic and episodic migraine

Results from a one-year study of efficacy and safety of Aimovig in chronic migraine ...

author_avatar
NASDAQ Market News

Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News